Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis.

Tettero, Jesse M; Al-Badri, Waleed K W; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; van Elssen, Catharina H M J; Fischer, Thomas; Gjertsen, Bjorn T; van Gorkom, Gwendolyn N Y; Gradowska, Patrycja; Greuter, Marjolein J E; Griskevicius, Laimonas; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Löwenberg, Bob; Ossenkoppele, Gert J; Janssen, Jeroen J W M; Cloos, Jacqueline

Tettero, Jesse M; Al-Badri, Waleed K W; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; van Elssen, Catharina H M J; Fischer, Thomas; Gjertsen, Bjorn T; van Gorkom, Gwendolyn N Y; Gradowska, Patrycja; Greuter, Marjolein J E; Griskevicius, Laimonas; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Löwenberg, Bob; Ossenkoppele, Gert J; Janssen, Jeroen J W M; Cloos, Jacqueline.

Afiliação

Tettero JM; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Al-Badri WKW; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands.
Ngai LL; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Bachas C; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Breems DA; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands.
van Elssen CHMJ; Department of Hematology, Amsterdam Univerisity Medical Centers location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Fischer T; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands.
Gjertsen BT; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
van Gorkom GNY; Department of Internal Medicine, Division of Hematology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Gradowska P; Department of Hematology and Oncology, Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany.
Greuter MJE; Department of Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
Griskevicius L; Department of Internal Medicine, Division of Hematology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Juliusson G; The Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) Data Center, Department of Hematology, Erasmus Medical Center (MC) Cancer Institute, Rotterdam, Netherlands.
Maertens J; Department of Epidemiology and Data Science, Amsterdam Univerisity Medical Centers, location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Manz MG; Hematology, Oncology, Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania.
Pabst T; Department of Hematology, Skanes University Hospital, Lund, Sweden.
Passweg J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.
Porkka K; Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland.
Löwenberg B; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
Ossenkoppele GJ; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
Janssen JJWM; Department of Medical Oncology, Inselspital, University Hospital, Bern, Switzerland.
Cloos J; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.